Advertisement
Advertisement

CTXR

CTXR logo

Citius Pharmaceuticals Inc. Common

0.73
USD
Sponsored
+0.05
+7.39%
Aug 11, 12:58 UTC -4
Open

Citius Pharmaceuticals Inc. Common Profile

About

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care and prescription products. Citius Pharmaceuticals, Inc. is headquartered in Cranford, New Jersey.

Info & Links

CEO

Leonard Mazur

Headquarters

11 Commerce Drive, First Floor
Cranford, NJ 07016, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.citiuspharma.com

Auditor

Wolf & Company, P.C.

Share holders

90

Employees

23

Citius Pharmaceuticals Inc. Common Statistics

Valuation Measures

Market Capitalization2

19.96M

Enterprise Value

15.37M

Enterprise Value/EBITDA(ttm)

-0.27

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.22

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

40.07%

Operating Margin(ttm)

--

Profit Margin(ttm)

-370.45%

Return on Equity(ttm)

-61.09%

Return on Invested Capital(ttm)

-75.64%

Return on Assets(ttm)

-35.36%

Income Statement

Revenue(ttm)

5.61M

Revenue Per Share(ttm)

0.20

Gross Profit(ttm)

4.49M

EBITDA(ttm)3

-56.02M

Net Income Available to Common(ttm)

-46.20M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.03

52-Week Change

-40.89%

S&P 500 52-Week Change

21.42%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

27.45M

Dividend Yield

0.00%

Float4

26.08M

% Held by Insiders

4.99%

% Held by Institutions

16.88%

Balance Sheet

Total Cash(mrq)

4.59M

Total Cash Per Share(mrq)

0.17

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.58%

Quick Ratio(mrq)

0.16%

Book Value Per Share(mrq)

3.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.64

Free Cash Flow(ytd)

-14.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement